# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA622396 | A | Stability in rat serum measured as % recovery at 1 min | Rattus norvegicus | 5 | organism-based format | Scientific Literature | ||
2. | ALA624895 | A | Stability in rat serum measured as % recovery at 10 mins | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
3. | ALA624058 | A | Stability in rat serum measured as % recovery at 2 hr | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
4. | ALA624060 | A | Stability in rat serum measured as % recovery at 3 mins | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
5. | ALA624062 | A | Stability in rat serum measured as % recovery at 5 mins | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
6. | ALA678820 | F | Inhibitory activity against accumulation of [14C]-labeled Linezolid within wild-type Escherichia coli K12 cells | Escherichia coli | 20 | cell-based format | Scientific Literature | ||
7. | ALA678487 | F | Antibacterial activity against Escherichia coli strain ATCC 25922 | Escherichia coli | 19 | organism-based format | Scientific Literature | ||
8. | ALA753625 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 0 ug/mL against PAM 1033 | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
9. | ALA753626 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 1.25 ug/mL against PAM 1033 | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
10. | ALA753627 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 10 ug/mL against PAM 1033. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
11. | ALA753628 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 2.50 ug/mL against PAM 1033. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
12. | ALA755643 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 20 ug/mL against PAM 1033. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
13. | ALA755644 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 40 ug/mL against PAM 1033. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
14. | ALA755645 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 50 ug/mL against PAM 1033. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
15. | ALA760428 | F | Minimum Inhibitory concentration required to reduce the MIC of levofloxacin by 8-fold against PAM 1033. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
16. | ALA760429 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 0 ug/mL against PAM 1034. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
17. | ALA760430 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 1.25 ug/mL against PAM 1034. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
18. | ALA760431 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 10 ug/mL against PAM 1034. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
19. | ALA760432 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 2.5 ug/mL against PAM 1034. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature | ||
20. | ALA760433 | F | Minimum inhibitory concentration of Levofloxacin in presence at a concentration of 20 ug/mL against PAM 1034. | Pseudomonas aeruginosa | 1 | organism-based format | Scientific Literature |